Differences of inflammatory cytokine profile in patients with vulnerable plaque: A coronary CTA study

Caroline Roesner1, Markus Goeller1, Dorette Raaz-Schrauder1

  • 1Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Cardiology, Erlangen, Germany.

Atherosclerosis
|April 28, 2022
PubMed

Insights

Inflammatory biomarkers like IL-1a and IL-17 are linked to coronary plaque volume and vulnerable plaque. Monocyte chemoattractant protein-1 (MCP-1) may offer protective effects against atherosclerosis progression.

Area of Science:

  • Cardiovascular disease research
  • Inflammation and immunology
  • Biomarker discovery

Background:

  • Atherosclerosis involves various pro- and anti-inflammatory biomarkers.
  • Understanding these biomarkers' association with coronary plaque is crucial.

Purpose of the Study:

  • To analyze the association between different biomarkers and coronary plaque volume.
  • To investigate the link between biomarkers and vulnerable plaque subcomponents.

Main Methods:

  • Coronary CT angiography (CTA) was performed on 301 patients.
  • Semi-automated software quantified total plaque volume (TPV) and non-calcified plaque volume (NCPV).
  • Serum cytokine levels were analyzed and correlated with plaque characteristics.

Main Results:

  • High plaque burden correlated with increased levels of IFNƔ, IL-1a, IL-2, IL-4, IL-10, IL-17 and decreased levels of IL-8, MCP-1.
  • Multivariable analysis identified IL-1a and Eotaxin as positively associated with vulnerable plaque, while MCP-1 showed an inverse association.
  • Elevated IL-17 levels were observed in patients with high vulnerable plaque burden.

Conclusions:

  • Cytokine profiles differ significantly based on coronary plaque volume.
  • IL-1a and IL-17 may promote atherosclerosis, while MCP-1 might have protective effects.
  • Further longitudinal studies are needed to explore therapeutic targets.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
31
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
138
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
237
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
58
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
46
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
60